SPINK5 Human shRNA Plasmid Kit (Locus ID 11005)
CAT#: TG309144
SPINK5 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4790.00
货期*
现货
规格
Product images

推荐一起购买 (2)
Specifications
Product Data | |
Product Name | SPINK5 Human shRNA Plasmid Kit (Locus ID 11005) |
Locus ID | 11005 |
UniProt ID | Q9NQ38 |
Synonyms | LEKTI; LETKI; NETS; NS; VAKTI |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | SPINK5 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 11005). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001127698, NM_001127699, NM_006846, NM_006846.1, NM_006846.2, NM_006846.3, NM_001127699.1, NM_001127698.1, BC141545, NM_006846.4, NM_001127698.2, NM_001127699.2 |
Summary | This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...